Get started Log in

HALEOSLABS — Haleos Labs News Story

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
IN₹4.53bn
Enterprise Value
IN₹5.77bn
Revenue
IN₹3.34bn

Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls

14/11/2022 11:07

Nov 14 (Reuters) - SMS Lifesciences India Ltd  SMSL.NS :
    * SEPT-QUARTER CONSOL NET PROFIT 31.2 MILLION RUPEES VERSUS
PROFIT
102.5 MILLION RUPEES YEAR AGO
    * SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 812.6 MILLION
RUPEES
VERSUS 867.5 MILLION RUPEES YEAR AGO

Source text for Eikon:  ID:nBSEv3BnX 
Further company coverage:  SMSL.NS 
 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Haleos Labs

Brief: Haleos Labs Entered Into Strategic Development Collaboration With Hrv Global Life Sciences
21/01/2026 08:11
SMS Lifesciences India soars; facility gets US FDA clearance
16/07/2025 09:34
Brief: SMS Lifesciences India Gets EIR With VAI Status From USFDA
16/07/2025 08:55
Brief: SMS Lifesciences India Dec-Quarter Consol Net Profit Rises
10/02/2023 10:43
Brief: Sms Lifesciences India Sept-Qtr Consol Net Profit Falls
14/11/2022 11:07